Which screening should be included in the teaching plan for a patient with a T lymphocyte immune deficiency?

In patients with T lymphocyte immune deficiency, there is an increased risk of developing malignancies. This is primarily due to the critical role T lymphocytes play in immune surveillance against tumor formation and progression. A diminished T cell function can lead to a reduced ability to detect and eliminate cancerous cells. Therefore, including malignancy screening in the teaching plan is essential for early detection and management of potential cancers.

While screening for allergies, antibody deficiency, and autoimmune disorders are also relevant in the context of immunodeficiencies, they do not specifically address the heightened risk of malignancy that arises from T lymphocyte deficiencies. Thus, focusing on malignancy screening is particularly important for improving patient outcomes in this scenario.